Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2
Abstract Simple Summary: Drug resistance is the key factor contributing to the therapeutic failure of lung cancer and the deaths…
Ramesh K. Ganju
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer
Abstract Transient receptor potential vanilloid type-2 (TRPV2) is an ion channel that is triggered by agonists like cannabidiol (CBD). Triple…
Cannabinoids as therapeutic agents in cancer: current status and future implications
Abstract The pharmacological importance of cannabinoids has been in study for several years. Cannabinoids comprise of (a) the active compounds…